Last reviewed · How we verify
Placebo (PBO) oral capsules — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo (PBO) oral capsules (Placebo (PBO) oral capsules) — AbbVie (prior sponsor, Abbott). Placebo contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect—the patient's expectation of benefit.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo (PBO) oral capsules TARGET | Placebo (PBO) oral capsules | AbbVie (prior sponsor, Abbott) | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo (PBO) oral capsules CI watch — RSS
- Placebo (PBO) oral capsules CI watch — Atom
- Placebo (PBO) oral capsules CI watch — JSON
- Placebo (PBO) oral capsules alone — RSS
Cite this brief
Drug Landscape (2026). Placebo (PBO) oral capsules — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-pbo-oral-capsules. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab